To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a parts per thousand yen12 of hepatic vein pressure gradient (HVPG)]. One-hundred and seven consecutive patients who underwent HVPG measurement in the PH group and 52 controls were included. The diameters of main portal vein (oMPV), superior mesenteric vein (oSMV), splenic vein (oSV), and left gastric vein, oMPV/oSV, oSMV/oSV, as well as estimated spleen volumes were evaluated on the CT scan. The grade of varix and ascites were also evaluated semi-quantitatively. We explored the statistically significant CT features related to severe PH and performed a logistic regression analysis for an estimation model for severe PH. oMPV/oSV and oSMV/oSV tended...
open5noPortal hypertension is the main driver of complications in patients with advanced chronic liv...
PURPOSE To assess liver perfusion-CT (P-CT) parameters derived from peak-splenic (PSE) versus peak-r...
open5noPortal hypertension is the main driver of complications in patients with advanced chronic liv...
To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a par...
To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a par...
To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a par...
Background & Aims: Clinically significant portal hypertension (CSPH) is a landmark in the natura...
Background & Aims: Clinically significant portal hypertension (CSPH) is a landmark in the natura...
Portal hypertension (PH) and the relative clinical manifestations represent major complications of a...
Portal hypertension (PH) and the relative clinical manifestations represent major complications of a...
Portal hypertension (PH) and the relative clinical manifestations represent major complications of a...
Vinaya Gaduputi,1 Harish Patel,1 Sailaja Sakam,1 Srivani Neshangi,1 Rafeeq Ahmed,1 Michael Lombino,2...
OBJECTIVE: The aim of this study was to determine whether and how the diameter of the vein that give...
PURPOSE To assess liver perfusion-CT (P-CT) parameters derived from peak-splenic (PSE) versus peak-r...
Portal hypertension is characterized by elevated pressure in portal venous system due to portal resi...
open5noPortal hypertension is the main driver of complications in patients with advanced chronic liv...
PURPOSE To assess liver perfusion-CT (P-CT) parameters derived from peak-splenic (PSE) versus peak-r...
open5noPortal hypertension is the main driver of complications in patients with advanced chronic liv...
To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a par...
To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a par...
To explore the CT signs which permit estimation of clinically severe portal hypertension (PH) [a par...
Background & Aims: Clinically significant portal hypertension (CSPH) is a landmark in the natura...
Background & Aims: Clinically significant portal hypertension (CSPH) is a landmark in the natura...
Portal hypertension (PH) and the relative clinical manifestations represent major complications of a...
Portal hypertension (PH) and the relative clinical manifestations represent major complications of a...
Portal hypertension (PH) and the relative clinical manifestations represent major complications of a...
Vinaya Gaduputi,1 Harish Patel,1 Sailaja Sakam,1 Srivani Neshangi,1 Rafeeq Ahmed,1 Michael Lombino,2...
OBJECTIVE: The aim of this study was to determine whether and how the diameter of the vein that give...
PURPOSE To assess liver perfusion-CT (P-CT) parameters derived from peak-splenic (PSE) versus peak-r...
Portal hypertension is characterized by elevated pressure in portal venous system due to portal resi...
open5noPortal hypertension is the main driver of complications in patients with advanced chronic liv...
PURPOSE To assess liver perfusion-CT (P-CT) parameters derived from peak-splenic (PSE) versus peak-r...
open5noPortal hypertension is the main driver of complications in patients with advanced chronic liv...